Hypercoagulability State Combined with Post-Treatment Hypofibrinolysis in Invasive Breast Cancer: A Seven-Year Follow-Up Evaluating Disease-Free and Overall Survival

Wrzeszcz, Katarzyna; Rhone, Piotr; Kwiatkowska, Katarzyna; Ruszkowska-Ciastek, Barbara

doi:10.3390/life13051106

Cited by 2 publications

(2 citation statements)

References 46 publications

(49 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…All surgery treatment procedures were conducted under standardized conditions. A detailed treatment strategy is included in our previous manuscript [14] and Table 1.…”

Section: Therapeutic Proceduresmentioning

confidence: 99%

Traditional Clinicopathological Biomarkers Still Determine Disease-Free and Overall Survival in Invasive Breast Cancer Patients: A Pilot Study

Wrzeszcz,

Kwiatkowska,

Rhone

et al. 2024

JCM

Self Cite

View full text Add to dashboard Cite

Background: Molecular classification, tumor diameter, Ki67 expression, and brachytherapy administration still act as the most potent potential predictors of breast cancer recurrence and overall survival. Methods: Over the period of 23 months, we included in the study 92 invasive breast cancer (IBrC) patients initially diagnosed at the Clinical Ward of Breast Cancer and Reconstructive Surgery, Oncology Center in Bydgoszcz, Poland. The probability of disease-free survival (DFS) and overall survival (OS) in relation to potential prognostic factors for the patients were determined using a Kaplan–Meier analysis, and univariate and multivariate Cox regression analyses evaluated the predictive factors of IBrC patients. The investigation of the potential prognostic model’s accuracy was analyzed using the ROC curve. Results: Patients with tumor size < 2 cm, Ki67 expression < 20%, luminal-A molecular subtype, and extra-dose brachytherapy boost administration displayed the most favorable prognosis according to breast cancer disease-free survival and overall survival. The estimated 5 year probability of DFS and OS rates in women with tumor diameter < 2 cm were 89% and 90%, respectively. In tumor diameter > 2 cm, the estimated 5 year probability of DFS was 73% and OS was 76%. Interestingly, the tumor diameter of 1.6 cm with a specificity of 60.5% and a sensitivity of 75% occurred as the best threshold point to differentiate patients with cancer recurrence from those without cancer progression. Conclusions: Our study provides essential information on the clinicopathological profile and future outcomes of early stage IBrC patients. Furthermore, the tumor diameter cut-off value of 1.6 cm discriminating between disease recurrence and those without disease progression patients represents an innovative direction for further research.

show abstract

“…All surgery treatment procedures were conducted under standardized conditions. A detailed treatment strategy is included in our previous manuscript [14] and Table 1.…”

Section: Therapeutic Proceduresmentioning

confidence: 99%

Traditional Clinicopathological Biomarkers Still Determine Disease-Free and Overall Survival in Invasive Breast Cancer Patients: A Pilot Study

Wrzeszcz,

Kwiatkowska,

Rhone

et al. 2024

JCM

Self Cite

View full text Add to dashboard Cite

show abstract

“…The key regulator of adipogenesis was found to be dysregulated in obese people, leading to an increase in the production of the plasminogen-activator inhibitor-1 (PLAI-1). PLAI-1 upregulation was associated with angiogenesis, the enhancement of cell adhesion, migration, and the inhibition of apoptosis, and it is suspected to be responsible for the breast micro-environment facilitating cancer development and metastasis [23][24][25].…”

Section: Introductionmentioning

confidence: 99%

Towards Understanding the Development of Breast Cancer: The Role of RhoJ in the Obesity Microenvironment

Bou Malhab,

Nair,

Qaisar

et al. 2024

Cells

View full text Add to dashboard Cite

Obesity is a growing pandemic with an increasing risk of inducing different cancer types, including breast cancer. Adipose tissue is proposed to be a major player in the initiation and progression of breast cancer in obese people. However, the mechanistic link between adipogenicity and tumorigenicity in breast tissues is poorly understood. We used in vitro and in vivo approaches to investigate the mechanistic relationship between obesity and the onset and progression of breast cancer. In obesity, adipose tissue expansion and remodeling are associated with increased inflammatory mediator’s release and anti-inflammatory mediators’ reduction.. In order to mimic the obesity micro-environment, we cultured cells in an enriched pro-inflammatory cytokine medium to which we added a low concentration of beneficial adipokines. Epithelial cells exposed to the obesity micro-environment were phenotypically transformed into mesenchymal-like cells, characterized by an increase in different mesenchymal markers and the acquisition of the major hallmarks of cancerous cells; these include sustained DNA damage, the activation of the ATR-Chk2 pathway, an increase in proliferation rate, cell invasion, and resistance to conventional chemotherapy. Transcriptomic analysis revealed that several genes, including RhoJ, CCL7, and MMP9, acted as potential major players in the observed phenomenon. The transcriptomics findings were confirmed in vitro using qRT-PCR and in vivo using high-fat-diet-fed mice. Our data suggests RhoJ as a potential novel molecular driver of tumor development in breast tissues and a mediator of cell resistance to conventional chemotherapy through PAK1 activation. These data propose that RhoJ is a potential target for therapeutic interventions in obese breast cancer patients.

show abstract

Hypercoagulability State Combined with Post-Treatment Hypofibrinolysis in Invasive Breast Cancer: A Seven-Year Follow-Up Evaluating Disease-Free and Overall Survival

Cited by 2 publications

References 46 publications

Traditional Clinicopathological Biomarkers Still Determine Disease-Free and Overall Survival in Invasive Breast Cancer Patients: A Pilot Study

Traditional Clinicopathological Biomarkers Still Determine Disease-Free and Overall Survival in Invasive Breast Cancer Patients: A Pilot Study

Towards Understanding the Development of Breast Cancer: The Role of RhoJ in the Obesity Microenvironment

Contact Info

Product

Resources

About